Esculentin-1GN

General Information


DRACP ID  DRACP03769

Peptide Name   Esculentin-1GN

Sequence  GLFSKKGGKGGKSWIKGVFKGIKGIGKEVGGDVIRTGIEIAACKIKGEC

Sequence Length  49

UniProt ID  A0A3G6VAR4 

PubChem CID  Not available

Origin  Animalia

Type  Native peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C225H379N63O61S2

Absent amino acids  HMNPQY

Common amino acids  G

Mass  586337

Pl  10.63

Basic residues  11

Acidic residues  4

Hydrophobic residues  16

Net charge  7

Boman Index  -3077

Hydrophobicity  -7.76

Aliphatic Index  85.51

Half Life 
  Mammalian: 5.5 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  5625

Absorbance 280nm  117.19

Polar residues  18

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 30427189

Title  Functional Characterization of a Novel Lipopolysaccharide-Binding Antimicrobial and Anti-Inflammatory Peptide in Vitro and in Vivo

Doi Not available

Year  2018

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  12416

DRACP is developed by Dr.Zheng's team.